Driehaus Capital Management LLC Relmada Therapeutics, Inc. Transaction History
Driehaus Capital Management LLC
- $10.3 Billion
- Q2 2025
A detailed history of Driehaus Capital Management LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 740,006 shares of RLMD stock, worth $436,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
740,006Holding current value
$436,603% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLMD
# of Institutions
51Shares Held
5.11MCall Options Held
0Put Options Held
0-
Acadian Asset Management LLC Boston, MA619KShares$365,4920.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$338,2550.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD397KShares$233,9430.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$214,8050.0% of portfolio
-
Geode Capital Management, LLC Boston, MA302KShares$178,3880.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $16.9M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...